In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes.

S Brocke; C Brautbar; L Steinman; O Abramsky; J Rothbard; D Neumann; S Fuchs; E Mozes

doi:10.1172/JCI113807

Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.

Find articles by Brocke, S. in: PubMed | Google Scholar

Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.

Find articles by Brautbar, C. in: PubMed | Google Scholar

Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.

Find articles by Steinman, L. in: PubMed | Google Scholar

Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.

Find articles by Abramsky, O. in: PubMed | Google Scholar

Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.

Find articles by Rothbard, J. in: PubMed | Google Scholar

Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.

Find articles by Neumann, D. in: PubMed | Google Scholar

Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.

Find articles by Fuchs, S. in: PubMed | Google Scholar

Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.

Find articles by Mozes, E. in: PubMed | Google Scholar

Published in Volume 82, Issue 6 on December 1, 1988
J Clin Invest. 1988;82(6):1894–1900. https://doi.org/10.1172/JCI113807.
© 1988 The American Society for Clinical Investigation

Published December 1, 1988 - Version history

To investigate which parts of the acetylcholine receptor are involved in the initiation and development of myasthenia gravis (MG), peptides representing different sequences of the human acetylcholine receptor alpha-subunit were synthesized. These peptides were tested for their ability to stimulate T cells of myasthenic patients and healthy control patients in proliferation assays and to bind to sera antibodies. Three of eight peptides discriminated significantly between the two groups in the proliferation assay, as well as in their ability to bind to serum antibodies. HLA-DR3 and DR5 were associated with proliferative responses to specific AChR peptides in the group of myasthenics. Acetylcholine receptor epitopes that might play a specific role in myasthenia gravis thus were demonstrated.

Version 1 (December 1, 1988): No description

In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes.

S Brocke, C Brautbar, L Steinman, O Abramsky, J Rothbard, D Neumann, S Fuchs, and E Mozes

Article tools

Metrics

Go to

In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes.

S Brocke, C Brautbar, L Steinman, O Abramsky, J Rothbard, D Neumann, S Fuchs, and E Mozes

Article tools

Metrics

Go to

Sign up for email alerts